Labcorp Holdings Inc.

Labcorp Holdings Inc. is a life sciences and laboratory services company headquartered in Burlington, North Carolina. The present holding structure was set up in 2023; in the same period its clinical research services business became independent as a separate company called Fortrea. Its shares trade on the New York Stock Exchange under the ticker LH, and it is a member of the S&P 500 index.

Activities run in two main lines. The diagnostics line performs routine and specialty laboratory tests ordered by physicians; genetic, oncology and pathology examinations, sample collection at patient service centers and tests for employers are part of this line. The drug development line offers laboratory services, early research support and central laboratory solutions for clinical studies to biopharmaceutical companies. Both lines are supported by digital tools that deliver test data to health systems and research sponsors.

When following Labcorp stock, test volumes, insurance reimbursement rules, research spending in the pharmaceutical sector and acquisitions in the laboratory sector are taken into account. On the LH page at Lzzo.com the price is shown in US dollars, and a price chart and technical indicators appear on the same page.